ESTABLISHMENT OF SORAFENIB-RESISTANT MOUSE RENAL CELL CARCINOMA RENCA CELLS AND CHARACTERIZATION OF THEIR ACQUIRED RESISTANT MECHANISM

被引：0
|
作者：
Kusuda, Yuji
Miyake, Hideaki
Sakai, Iori
Fujisawa, Masato
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
299
引用
收藏
页码：E121 / E121
页数：1
相关论文
共 50 条
  • [1] Characterization of mechanism involved in acquired resistance to sorafenib in a mouse renal cell cancer RenCa model
    Harada, K.
    Miyake, H.
    Kusuda, Y.
    Fujisawa, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (09): : 801 - 806
  • [2] Characterization of mechanism involved in acquired resistance to sorafenib in a mouse renal cell cancer RenCa model
    K. Harada
    H. Miyake
    Y. Kusuda
    M. Fujisawa
    Clinical and Translational Oncology, 2014, 16 : 801 - 806
  • [3] ESTABLISHMENT OF SUNITINIB-RESISTANT HUMAN RENAL CELL CARCINOMA ACHN CELLS AND CHARCTERIZATION OF THEIR ACQUIRED RESISTANT MECHANISM
    Sakai, Iori
    Miyake, Hideaki
    Terakawa, Tomoaki
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2010, 183 (04): : E31 - E31
  • [4] Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells
    Shi, Tingting
    Iwama, Hisakazu
    Fujita, Koji
    Kobara, Hideki
    Nishiyama, Noriko
    Fujihara, Shintaro
    Goda, Yasuhiro
    Yoneyama, Hirohito
    Morishita, Asahiro
    Tani, Joji
    Yamada, Mari
    Nakahara, Mai
    Takuma, Kei
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [5] HBx Modulates Drug Resistance of Sorafenib-Resistant Hepatocellular Carcinoma Cells
    Liu, Yaping
    Liu, Xu
    Luo, Miaosha
    Li, Yarui
    Li, Hongxia
    DISCOVERY MEDICINE, 2023, 35 (179) : 1035 - 1042
  • [6] TIGAR Overexpression Increases Chemosensitivity in Sorafenib-resistant Hepatocellular Carcinoma Cells
    Derdak, Zoltan
    Harb, Ragheb
    Wands, Jack R.
    HEPATOLOGY, 2014, 60 : 811A - 811A
  • [7] Adjutant therapeutic strategy for sorafenib-resistant hepatocellular carcinoma
    Peng, Syue-Wei
    Lin, Yi-Heng
    Teng, Ming-Hao
    Lai, Hung-Cheng
    Chang, Te-Sheng
    Huang, Yen-Hua
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma
    Luo, Jialiang
    Li, Lei
    Zhu, Zhengyumeng
    Chang, Bo
    Deng, Fan
    Wang, Di
    Lu, Xiao
    Zuo, Daming
    Chen, Qingyun
    Zhou, Jia
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 154
  • [9] Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation
    Zhang, Zhengguang
    Wu, Haitao
    Zhang, Yajie
    Shen, Cunsi
    Zhou, Fuqiong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (01) : 559 - 574
  • [10] Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation
    Zhengguang Zhang
    Haitao Wu
    Yajie Zhang
    Cunsi Shen
    Fuqiong Zhou
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 559 - 574
12345